Sources: SAHPRA, NHS, World Health Organization.
The full scope at Ascend includes: Obesity and overweight with comorbidities - full workup, GLP-1 candidacy assessment, lifestyle integration Type 2 diabetes with weight management goals - GLP-1 medications often address both indications simultaneously Hypertension tied to weight - coordinated medication review and lifestyle work Dyslipidemia and metabolic syndrome - lipids often improve markedly with weight loss Prediabetes - HbA1c 5.7-6.4% range, where intervention can prevent progression Fatty liver disease (MASLD) - weight loss is the primary intervention
Without a log, these patterns stay invisible
* $99/mo average price when you purchase 6 months of GLP-1 therapy treatment
Topical pharmaceutical formulation patent WO2016132159
Molecular Role of Semaglutide in Skeletal Muscle Homeostasis The interaction between GLP-1 and GLP-1R is observed to present a strong impact on the AMPK signaling within skeletal muscle tissue, augmenting mitochondrial biogenesis, oxidative phosphorylation and metabolism of muscle tissue [180]
